Literature DB >> 3007964

The role of metabolic acidosis in causing uremic hyperphosphatemia.

G Barsotti, M Lazzeri, C Cristofano, M Cerri, S Lupetti, S Giovannetti.   

Abstract

Metabolic acidosis was corrected within 1 h in 7 chronic anuric uremic patients on maintenance hemodialysis and, in the course of a week, in 11 other patients on conservative therapy. These patients were on a diet supplying constant amounts of phosphate throughout the duration of the study. In the former group the intravenous infusion of sodium bicarbonate was used, and, in the latter, the oral administration of sodium citrate. In both groups serum phosphate was found to decrease significantly. In the patients on conservative therapy, phosphaturia also had significantly decreased while no changes occurred in their daily fecal loss of phosphate that was measured in 3 patients. These findings indicate that metabolic acidosis is one of the causes of hyperphosphatemia in chronic uremic patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007964

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  7 in total

1.  NH4Cl Treatment Prevents Tissue Calcification in Klotho Deficiency.

Authors:  Christina B Leibrock; Ioana Alesutan; Jakob Voelkl; Tatsiana Pakladok; Diana Michael; Erwin Schleicher; Zahra Kamyabi-Moghaddam; Leticia Quintanilla-Martinez; Makoto Kuro-o; Florian Lang
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

2.  Glycaemia and phosphatemia after oral glucose and maltitol ingestion in subjects from two different race groups: preliminary evidence of inter-race differences in metabolism and possible implications for urinary stone disease.

Authors:  Takalani Theka; Allen Rodgers
Journal:  Int Urol Nephrol       Date:  2017-05-19       Impact factor: 2.370

Review 3.  Public health approach to addressing hyperphosphatemia among dialysis patients.

Authors:  Ashwini R Sehgal; Catherine Sullivan; Janeen B Leon; Karil Bialostosky
Journal:  J Ren Nutr       Date:  2008-05       Impact factor: 3.655

Review 4.  Secondary hyperparathyroidism in children with chronic renal failure: pathogenesis and treatment.

Authors:  Cheryl P Sanchez
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  A quantitative analysis of the acidosis of cardiac arrest: a prospective observational study.

Authors:  Jun Makino; Shigehiko Uchino; Hiroshi Morimatsu; Rinaldo Bellomo
Journal:  Crit Care       Date:  2005-05-23       Impact factor: 9.097

Review 6.  Therapeutic Interference With Vascular Calcification-Lessons From Klotho-Hypomorphic Mice and Beyond.

Authors:  Florian Lang; Christina Leibrock; Lisann Pelzl; Meinrad Gawaz; Burkert Pieske; Ioana Alesutan; Jakob Voelkl
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-04       Impact factor: 5.555

Review 7.  Hyperphosphatemia Management in Patients with Chronic Kidney Disease.

Authors:  Ahmed M Shaman; Stefan R Kowalski
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.